Connection

MAHBOOB ALAM to Coronary Artery Disease

This is a "connection" page, showing publications MAHBOOB ALAM has written about Coronary Artery Disease.
Connection Strength

5.801
  1. Comparative analysis of revascularization with percutaneous coronary intervention versus coronary artery bypass surgery for patients with end-stage renal disease: a nationwide inpatient sample database. Expert Rev Cardiovasc Ther. 2021 Aug; 19(8):763-768.
    View in: PubMed
    Score: 0.470
  2. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression. Clin Cardiol. 2019 Nov; 42(11):1071-1078.
    View in: PubMed
    Score: 0.411
  3. Outcomes of Robotically Assisted Versus Manual Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. J Invasive Cardiol. 2019 Aug; 31(8):199-203.
    View in: PubMed
    Score: 0.403
  4. Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. Am J Cardiol. 2017 Nov 01; 120(9):1514-1520.
    View in: PubMed
    Score: 0.356
  5. The Role of Intracoronary Plaque Imaging with Intravascular Ultrasound, Optical Coherence Tomography, and Near-Infrared Spectroscopy in Patients with Coronary Artery Disease. Curr Atheroscler Rep. 2016 09; 18(9):57.
    View in: PubMed
    Score: 0.334
  6. Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. Am J Cardiol. 2013 Sep 01; 112(5):615-22.
    View in: PubMed
    Score: 0.266
  7. Use of drug-eluting stents or coronary artery bypass grafting in patients with unprotected left main coronary artery disease. Am J Cardiol. 2013 Mar 15; 111(6):921-2.
    View in: PubMed
    Score: 0.263
  8. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2):372-82.
    View in: PubMed
    Score: 0.256
  9. Unprotected left main coronary artery disease--coronary artery bypass graft versus percutaneous coronary intervention: lessons from randomized clinical trials. J Card Surg. 2013 May; 28(3):276-7.
    View in: PubMed
    Score: 0.248
  10. Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6.
    View in: PubMed
    Score: 0.246
  11. Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy. Int J Cardiol. 2012 Apr 05; 156(1):101-4.
    View in: PubMed
    Score: 0.242
  12. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85.
    View in: PubMed
    Score: 0.230
  13. Machine learning and computational fluid dynamics derived FFRCT demonstrate comparable diagnostic performance in patients with coronary artery disease; A Systematic Review and Meta-Analysis. J Cardiovasc Comput Tomogr. 2025 Mar-Apr; 19(2):232-246.
    View in: PubMed
    Score: 0.150
  14. Trends and Disparities in Coronary Artery Disease and Obesity-Related Mortality in the United States From 1999-2022. Endocrinol Diabetes Metab. 2024 Nov; 7(6):e70010.
    View in: PubMed
    Score: 0.147
  15. Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clin Cardiol. 2024 Oct; 47(10):e70026.
    View in: PubMed
    Score: 0.146
  16. The Current State of Coronary Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Interventions. Curr Cardiol Rep. 2024 Sep; 26(9):919-933.
    View in: PubMed
    Score: 0.144
  17. Clinical Outcomes of Cardiogenic Shock Due to Spontaneous Coronary Artery Dissection Versus Cardiogenic Shock Due to Coronary Artery Disease. Crit Pathw Cardiol. 2024 Sep 01; 23(3):141-148.
    View in: PubMed
    Score: 0.141
  18. Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease. Am J Med. 2023 12; 136(12):1147-1159.
    View in: PubMed
    Score: 0.134
  19. Revascularization Options for Left Main Disease: What Clinicians Need to Know. Curr Atheroscler Rep. 2023 06; 25(6):267-273.
    View in: PubMed
    Score: 0.133
  20. Peripheral Artery Disease on The Prognosis Value of Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Retrospective, Single-Center Cohort Study. Heart Surg Forum. 2021 Oct 19; 24(5):E887-E892.
    View in: PubMed
    Score: 0.119
  21. Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database). Am J Cardiol. 2021 08 15; 153:142-144.
    View in: PubMed
    Score: 0.116
  22. Safety and Efficacy of Colchicine in Patients with Stable CAD and ACS: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2021 Nov; 21(6):659-668.
    View in: PubMed
    Score: 0.116
  23. Instantaneous Wave-Free Ratio (iFR) Correlates With Fractional Flow Reserve (FFR) Assessment of Coronary Artery Stenoses and Myocardial Bridges in Children. J Invasive Cardiol. 2020 05; 32(5):176-179.
    View in: PubMed
    Score: 0.108
  24. Sex-specific association of monocyte count to high-density lipoprotein ratio with SYNTAX score in patients with suspected stable coronary artery disease. Medicine (Baltimore). 2019 Oct; 98(41):e17536.
    View in: PubMed
    Score: 0.103
  25. Coronary artery disease in a child with homozygous familial hypercholesterolemia: Regression after liver transplantation. J Clin Lipidol. 2019 Nov - Dec; 13(6):880-886.
    View in: PubMed
    Score: 0.103
  26. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Cardiovasc Drugs Ther. 2016 Apr; 30(2):189-98.
    View in: PubMed
    Score: 0.081
  27. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol. 2015 Apr 15; 115(8):1013-8.
    View in: PubMed
    Score: 0.075
  28. Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. Am J Cardiol. 2013 Nov 01; 112(9):1287-92.
    View in: PubMed
    Score: 0.067
  29. Coronary artery bypass graft surgery remains the standard of care for patients with diabetes. Semin Thorac Cardiovasc Surg. 2013; 25(2):97-9.
    View in: PubMed
    Score: 0.065
  30. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol. 2012 Oct 01; 110(7):919-23.
    View in: PubMed
    Score: 0.062
  31. National Trends, Mortality and Outcomes in Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention in the United States. Crit Pathw Cardiol. 2024 Dec 01; 23(4):202-206.
    View in: PubMed
    Score: 0.036
  32. A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:94-96.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.